PAK3 and attention deficit-hyperactivity disorder: Variations in the GluA1 subunit of AMPA receptors, one of PAK3-specific targets, are associated with moderate to severe ID and sometimes epilepsy, ASD, ADHD and movement disorders (Ismail et al., 2022).